Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years (2024)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; KAMIDAI, NICOLE MIKI - ICB
- Unidade: ICB
- DOI: 10.36922/an.2903
- Subjects: FISIOLOGIA; MODELOS ANIMAIS DE DOENÇAS; ROEDORES; DOENÇAS NEURODEGENERATIVAS; DOENÇA DE PARKINSON
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Advanced in Neurology
- ISSN: 2810-9619
- Volume/Número/Paginação/Ano: v. 3, n. 3, art. 2903, 19 p., 2024
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
FERREIRA, Ana Flávia Fernandes et al. Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years. Advanced in Neurology, v. 3, n. 3, p. 19 , 2024Tradução . . Disponível em: https://doi.org/10.36922/an.2903. Acesso em: 28 dez. 2025. -
APA
Ferreira, A. F. F., Meira Neta, M. da S., Lemuchi, L. M., Bianchetti, M. E., Kamidai, N. M., Kilinsky, L. M., & Britto, L. R. G. de. (2024). Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years. Advanced in Neurology, 3( 3), 19 . doi:10.36922/an.2903 -
NLM
Ferreira AFF, Meira Neta M da S, Lemuchi LM, Bianchetti ME, Kamidai NM, Kilinsky LM, Britto LRG de. Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years [Internet]. Advanced in Neurology. 2024 ; 3( 3): 19 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.36922/an.2903 -
Vancouver
Ferreira AFF, Meira Neta M da S, Lemuchi LM, Bianchetti ME, Kamidai NM, Kilinsky LM, Britto LRG de. Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years [Internet]. Advanced in Neurology. 2024 ; 3( 3): 19 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.36922/an.2903 - Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Mitochondrial abnormalities in neurological disorders
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- The role of interleukin-17 in neurological disorders
- Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
- Efeitos do exercício físico na função e biogênese mitocondrial em modelo de doença de Parkinson induzido por 6-hidroxidopamina
- Association between thyroid function and Alzheimer’s disease: a systematic review
Informações sobre o DOI: 10.36922/an.2903 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
